Actively Recruiting
Prosthesis Versus Active Exercise Program in Patients With Rotator Cuff Arthropathy
Led by University of Aarhus · Updated on 2025-04-17
102
Participants Needed
8
Research Sites
909 weeks
Total Duration
On this page
Sponsors
U
University of Aarhus
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Reverse shoulder arthroplasty (RSA) is a well-established treatment for rotator cuff arthropathy. However, the effectiveness of RSA has not been compared to non-surgical treatment in a randomised controlled trial. Shoulder exercises may be an effective treatment for reducing pain and improving function in glenohumeral osteoarthritis. The primary aim of this trial is to examine if RSA followed by standard postsurgical rehabilitation is superior to a 12-week exercise programme in patients with rotator cuff arthropathy eligible for unilateral RSA. The investigators hypothesise that surgical intervention followed by standard rehabilitation, results in clinically relevant (14-point, on a scale from 0-100) improvement compared to the exercise intervention.
CONDITIONS
Official Title
Prosthesis Versus Active Exercise Program in Patients With Rotator Cuff Arthropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 60-85 years
- Eligible for reverse shoulder arthroplasty
- Rotator cuff arthropathy classified as Hamada grade 3, 4, or 5
You will not qualify if you...
- Previous proximal humerus or glenoid fracture
- Planned upper extremity surgery within six months
- Rheumatoid arthritis or other arthritis types not primary glenohumeral osteoarthritis
- Current cancer treatment with chemotherapy, immunotherapy, or radiotherapy
- Neurological diseases affecting shoulder movement (e.g., stroke disability, multiple sclerosis, Parkinson's, Alzheimer's)
- Mental inability to participate or planned absence over 14 days in first 3 months
- Unable to communicate in the study country's language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Aarhus University Hospital
Aarhus N, Denmark
Actively Recruiting
2
Esbjerg Hospital
Esbjerg, Denmark, 6700
Actively Recruiting
3
Aalborg University Hospital
Farsø, Denmark, 9640
Actively Recruiting
4
Silkeborg Regional Hospital
Silkeborg, Denmark, 8600
Actively Recruiting
5
Viborg Regional Hospital
Viborg, Denmark, 8800
Actively Recruiting
6
Tartu University Hospital
Tartu, Estonia
Actively Recruiting
7
Tampere University Hospital
Tampere, Finland, 33521
Actively Recruiting
8
Oslo University Hospital
Oslo, Norway, 4956
Actively Recruiting
Research Team
J
Josefine B. Larsen, MSc
CONTACT
I
Inger Mechlenburg, Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here